Aspartate 0 9 0 9 B-clinical_variable
transaminase 10 22 10 22 I-clinical_variable
( 23 24 23 24 I-clinical_variable
AST 24 27 24 27 I-clinical_variable
) 27 28 27 28 I-clinical_variable
and 29 32 29 32 O
alanine 33 40 33 40 B-clinical_variable
transaminase 41 53 41 53 I-clinical_variable
( 54 55 54 55 I-clinical_variable
ALT 55 58 55 58 I-clinical_variable
) 58 59 58 59 I-clinical_variable
≤2.5 60 64 60 64 O
times 65 70 65 70 I-upper_bound
the 71 74 71 74 I-upper_bound
upper 75 80 75 80 I-upper_bound
limit 81 86 81 86 I-upper_bound
of 87 89 87 89 I-upper_bound
normal 90 96 90 96 I-upper_bound
( 97 98 97 98 I-upper_bound
ULN 98 101 98 101 I-upper_bound
) 101 102 101 102 I-upper_bound

Bilirubin 0 9 103 112 B-clinical_variable
≤1.5 10 14 113 117 O
mg 15 17 118 120 I-upper_bound
/ 17 18 120 121 I-upper_bound
dL 18 20 121 123 I-upper_bound
( 21 22 124 125 O
or 22 24 125 127 O
≤26 25 28 128 131 O
µmol 29 33 132 136 I-upper_bound
/ 33 34 136 137 I-upper_bound
L 34 35 137 138 I-upper_bound
) 35 36 138 139 O

CPK 0 3 140 143 B-clinical_variable
≤2.5 4 8 144 148 O
times 9 14 149 154 I-upper_bound
the 15 18 155 158 I-upper_bound
ULN 19 22 159 162 I-upper_bound

Left 0 4 163 167 B-clinical_variable
ventricular 5 16 168 179 I-clinical_variable
ejection 17 25 180 188 I-clinical_variable
fraction 26 34 189 197 I-clinical_variable
( 35 36 198 199 I-clinical_variable
LVEF 36 40 199 203 I-clinical_variable
) 40 41 203 204 I-clinical_variable
≥ 42 43 205 206 O
institutional 44 57 207 220 O
lower 58 63 221 226 O
limit 64 69 227 232 O
of 70 72 233 235 O
normal 73 79 236 242 O
as 80 82 243 245 O
measured 83 91 246 254 O
by 92 94 255 257 O
multigated 95 105 258 268 B-treatment
acquisition 106 117 269 280 I-treatment
scan 118 122 281 285 I-treatment
or 123 125 286 288 O
2 126 127 289 290 B-treatment
- 127 128 290 291 I-treatment
dimensional 128 139 291 302 I-treatment
( 140 141 303 304 I-treatment
2 141 142 304 305 I-treatment
- 142 143 305 306 I-treatment
D 143 144 306 307 I-treatment
) 144 145 307 308 I-treatment
echocardiogram 146 160 309 323 I-treatment
within 161 167 324 330 O
28 168 170 331 333 B-upper_bound
days 171 175 334 338 I-upper_bound
prior 176 181 339 344 I-upper_bound
to 182 184 345 347 O
start 185 190 348 353 O
of 191 193 354 356 O
therapy 194 201 357 364 B-treatment
and 202 205 365 368 O
no 206 208 369 371 O
clinically 209 219 372 382 O
significant 220 231 383 394 O
abnormalities 232 245 395 408 O
on 246 248 409 411 O
a 249 250 412 413 O
12 251 253 414 416 B-treatment
- 253 254 416 417 I-treatment
lead 254 258 417 421 I-treatment
electrocardiogram 259 276 422 439 I-treatment
( 277 278 440 441 I-treatment
ECG 278 281 441 444 I-treatment
) 281 282 444 445 I-treatment

Patients 0 8 446 454 O
with 9 13 455 459 O
a 14 15 460 461 O
past 16 20 462 466 O
cancer 21 27 467 473 B-cancer
history 28 35 474 481 O
( 36 37 482 483 O
within 37 43 483 489 O
2 44 45 490 491 B-upper_bound
years 46 51 492 497 I-upper_bound
of 52 54 498 500 O
entry 55 60 501 506 O
) 60 61 506 507 O
and/or 62 68 508 514 O
ongoing 69 76 515 522 O
active 77 83 523 529 O
malignancy 84 94 530 540 B-cancer
or 95 97 541 543 O
substantial 98 109 544 555 O
potential 110 119 556 565 O
for 120 123 566 569 O
recurrence 124 134 570 580 O
must 135 139 581 585 O
be 140 142 586 588 O
discussed 143 152 589 598 O
with 153 157 599 603 O
the 158 161 604 607 O
Sponsor 162 169 608 615 O
before 170 176 616 622 O
study 177 182 623 628 O
entry 183 188 629 634 O

Serum 0 5 635 640 B-clinical_variable
albumin 6 13 641 648 I-clinical_variable
≥3.2 14 18 649 653 O
g 19 20 654 655 I-lower_bound
/ 20 21 655 656 I-lower_bound
dL 21 23 656 658 I-lower_bound
( 24 25 659 660 O
or 25 27 660 662 O
≥32 28 31 663 666 O
g 32 33 667 668 I-lower_bound
/ 33 34 668 669 I-lower_bound
L 34 35 669 670 I-lower_bound
) 35 36 670 671 O
in 37 39 672 674 O
the 40 43 675 678 O
absence 44 51 679 686 O
of 52 54 687 689 O
receipt 55 62 690 697 O
of 63 65 698 700 O
( 66 67 701 702 B-treatment
IV 67 69 702 704 I-treatment
) 69 70 704 705 I-treatment
albumin 71 78 706 713 I-treatment
within 79 85 714 720 O
the 86 89 721 724 O
previous 90 98 725 733 B-upper_bound
72 99 101 734 736 I-upper_bound
hours 102 107 737 742 I-upper_bound

Serum 0 5 743 748 B-clinical_variable
creatinine 6 16 749 759 I-clinical_variable
≤1.5 17 21 760 764 O
mg 22 24 765 767 I-upper_bound
/ 24 25 767 768 I-upper_bound
dL 25 27 768 770 I-upper_bound
( 28 29 771 772 O
or 29 31 772 774 O
≤114 32 36 775 779 O
µmol 37 41 780 784 I-upper_bound
/ 41 42 784 785 I-upper_bound
L 42 43 785 786 I-upper_bound
) 43 44 786 787 O

agrees 0 6 788 794 B-contraception_consent
to 7 9 795 797 I-contraception_consent
use 10 13 798 801 I-contraception_consent
acceptable 14 24 802 812 I-contraception_consent
contraceptive 25 38 813 826 I-contraception_consent
methods 39 46 827 834 I-contraception_consent
for 47 50 835 838 O
the 51 54 839 842 O
duration 55 63 843 851 O
of 64 66 852 854 O
time 67 71 855 859 O
in 72 74 860 862 O
the 75 78 863 866 O
study 79 84 867 872 O
, 84 85 872 873 O
and 86 89 874 877 O
to 90 92 878 880 O
continue 93 101 881 889 B-contraception_consent
to 102 104 890 892 I-contraception_consent
use 105 108 893 896 I-contraception_consent
acceptable 109 119 897 907 I-contraception_consent
contraceptive 120 133 908 921 I-contraception_consent
methods 134 141 922 929 I-contraception_consent
for 142 145 930 933 O
2 146 147 934 935 B-upper_bound
months 148 154 936 942 I-upper_bound
after 155 160 943 948 I-upper_bound
the 161 164 949 952 O
last 165 169 953 957 O
SL-401 170 176 958 964 B-treatment
infusion 177 185 965 973 I-treatment

carcinoma 0 9 974 983 B-cancer
in 10 12 984 986 O
situ 13 17 987 991 O
( 18 19 992 993 O
including 19 28 993 1002 O
superficial 29 40 1003 1014 B-cancer
bladder 41 48 1015 1022 I-cancer
cancer 49 55 1023 1029 I-cancer
) 55 56 1029 1030 O

cervical 0 8 1031 1039 B-cancer
intraepithelial 9 24 1040 1055 I-cancer
neoplasia 25 34 1056 1065 I-cancer

female 0 6 1066 1072 B-gender

has 0 3 1073 1076 O
an 4 6 1077 1079 O
Eastern 7 14 1080 1087 B-clinical_variable
Cooperative 15 26 1088 1099 I-clinical_variable
Oncology 27 35 1100 1108 I-clinical_variable
Group 36 41 1109 1114 I-clinical_variable
( 42 43 1115 1116 I-clinical_variable
ECOG 43 47 1116 1120 I-clinical_variable
) 47 48 1120 1121 I-clinical_variable
performance 49 60 1122 1133 I-clinical_variable
score 61 66 1134 1139 I-clinical_variable
of 67 69 1140 1142 O
0 70 71 1143 1144 B-lower_bound
- 71 72 1144 1145 O
2 72 73 1145 1146 B-upper_bound

has 0 3 1147 1150 O
an 4 6 1151 1153 O
absolute 7 15 1154 1162 B-clinical_variable
neutrophil 16 26 1163 1173 I-clinical_variable
count 27 32 1174 1179 I-clinical_variable
( 33 34 1180 1181 I-clinical_variable
ANC 34 37 1181 1184 I-clinical_variable
) 37 38 1184 1185 I-clinical_variable
≥0.5×10⁹/L 39 49 1186 1196 O

has 0 3 1197 1200 O
an 4 6 1201 1203 O
active 7 13 1204 1210 O
malignancy 14 24 1211 1221 B-cancer
and/or 25 31 1222 1228 O
cancer 32 38 1229 1235 B-cancer
history 39 46 1236 1243 O
( 47 48 1244 1245 O
excluding 48 57 1245 1254 O
myeloproliferative 58 76 1255 1273 B-chronic_disease
disorders 77 86 1274 1283 I-chronic_disease
and 87 90 1284 1287 O
concomitant 91 102 1288 1299 O
myeloid 103 110 1300 1307 B-cancer
malignancies 111 123 1308 1320 I-cancer
as 124 126 1321 1323 O
specified 127 136 1324 1333 O
in 137 139 1334 1336 O
the 140 143 1337 1340 O
inclusion 144 153 1341 1350 O
criteria 154 162 1351 1359 O
) 162 163 1359 1360 O
that 164 168 1361 1365 O
can 169 172 1366 1369 O
confound 173 181 1370 1378 O
the 182 185 1379 1382 O
assessment 186 196 1383 1393 O
of 197 199 1394 1396 O
the 200 203 1397 1400 O
study 204 209 1401 1406 O
endpoints 210 219 1407 1416 O

has 0 3 1417 1420 O
clinically 4 14 1421 1431 O
significant 15 26 1432 1443 O
cardiovascular 27 41 1444 1458 B-chronic_disease
disease 42 49 1459 1466 I-chronic_disease
( 50 51 1467 1468 O
e.g. 51 55 1468 1472 O
, 55 56 1472 1473 O
uncontrolled 57 69 1474 1486 O
or 70 72 1487 1489 O
any 73 76 1490 1493 O
New 77 80 1494 1497 B-clinical_variable
York 81 85 1498 1502 I-clinical_variable
Heart 86 91 1503 1508 I-clinical_variable
Association 92 103 1509 1520 I-clinical_variable
Class 104 109 1521 1526 I-clinical_variable
3 110 111 1527 1528 B-lower_bound
or 112 114 1529 1531 O
4 115 116 1532 1533 B-upper_bound
congestive 117 127 1534 1544 B-chronic_disease
heart 128 133 1545 1550 I-chronic_disease
failure 134 141 1551 1558 I-chronic_disease

has 0 3 1559 1562 O
evidence 4 12 1563 1571 O
of 13 15 1572 1574 O
active 16 22 1575 1581 O
or 23 25 1582 1584 O
chronic 26 33 1585 1592 O
Hepatitis 34 43 1593 1602 B-chronic_disease
B 44 45 1603 1604 I-chronic_disease
or 46 48 1605 1607 O
Hepatitis 49 58 1608 1617 B-chronic_disease
C 59 60 1618 1619 I-chronic_disease
infection 61 70 1620 1629 O

has 0 3 1630 1633 O
known 4 9 1634 1639 O
human 10 15 1640 1645 B-chronic_disease
immunodeficiency 16 32 1646 1662 I-chronic_disease
virus 33 38 1663 1668 I-chronic_disease
( 39 40 1669 1670 I-chronic_disease
HIV 40 43 1670 1673 I-chronic_disease
) 43 44 1673 1674 I-chronic_disease

has 0 3 1675 1678 O
persistent 4 14 1679 1689 O
clinically 15 25 1690 1700 O
significant 26 37 1701 1712 O
toxicities 38 48 1713 1723 O
Grade 49 54 1724 1729 O
≥2 55 57 1730 1732 O
from 58 62 1733 1737 O
previous 63 71 1738 1746 B-treatment
chemotherapy 72 84 1747 1759 I-treatment
not 85 88 1760 1763 O
readily 89 96 1764 1771 O
controlled 97 107 1772 1782 O
by 108 110 1783 1785 O
supportive 111 121 1786 1796 O
measures 122 130 1797 1805 O
( 131 132 1806 1807 O
excluding 132 141 1807 1816 O
alopecia 142 150 1817 1825 B-chronic_disease
, 150 151 1825 1826 O
nausea 152 158 1827 1833 B-chronic_disease
, 158 159 1833 1834 O
and 160 163 1835 1838 O
fatigue 164 171 1839 1846 B-chronic_disease
) 171 172 1846 1847 O

has 0 3 1848 1851 O
previously 4 14 1852 1862 O
received 15 23 1863 1871 O
treatment 24 33 1872 1881 B-treatment
with 34 38 1882 1886 I-treatment
SL-401 39 45 1887 1893 I-treatment
or 46 48 1894 1896 O
has 49 52 1897 1900 O
a 53 54 1901 1902 O
known 55 60 1903 1908 O
hypersensitivity 61 77 1909 1925 O
to 78 80 1926 1928 O
any 81 84 1929 1932 O
components 85 95 1933 1943 O
of 96 98 1944 1946 O
the 99 102 1947 1950 O
drug 103 107 1951 1955 O
product 108 115 1956 1963 O

has 0 3 1964 1967 O
received 4 12 1968 1976 O
treatment 13 22 1977 1986 B-treatment
with 23 27 1987 1991 O
another 28 35 1992 1999 O
investigational 36 51 2000 2015 B-treatment
agent 52 57 2016 2021 I-treatment
within 58 64 2022 2028 O
14 65 67 2029 2031 B-upper_bound
days 68 72 2032 2036 I-upper_bound
of 73 75 2037 2039 O
study 76 81 2040 2045 O
entry 82 87 2046 2051 O
or 88 90 2052 2054 O
concurrent 91 101 2055 2065 O
treatment 102 111 2066 2075 O
with 112 116 2076 2080 O
another 117 124 2081 2088 O
investigational 125 140 2089 2104 O
agent 141 146 2105 2110 O

has 0 3 2111 2114 O
received 4 12 2115 2123 O
treatment 13 22 2124 2133 B-treatment
with 23 27 2134 2138 O
chemotherapy 28 40 2139 2151 B-treatment
, 40 41 2151 2152 O
wide 42 46 2153 2157 B-treatment
- 46 47 2157 2158 I-treatment
field 47 52 2158 2163 I-treatment
radiation 53 62 2164 2173 I-treatment
, 62 63 2173 2174 O
or 64 66 2175 2177 O
biologic 67 75 2178 2186 B-treatment
therapy 76 83 2187 2194 I-treatment
within 84 90 2195 2201 O
14 91 93 2202 2204 B-upper_bound
days 94 98 2205 2209 I-upper_bound
of 99 101 2210 2212 O
study 102 107 2213 2218 O
entry 108 113 2219 2224 O

has 0 3 2225 2228 O
signed 4 10 2229 2235 O
informed 11 19 2236 2244 O
consent 20 27 2245 2252 O
prior 28 33 2253 2258 O
to 34 36 2259 2261 O
initiation 37 47 2262 2272 O
of 48 50 2273 2275 O
any 51 54 2276 2279 O
study 55 60 2280 2285 O
- 60 61 2285 2286 O
specific 61 69 2286 2294 O
procedures 70 80 2295 2305 O
or 81 83 2306 2308 O
treatment 84 93 2309 2318 B-treatment

has 0 3 2319 2322 O
uncontrolled 4 16 2323 2335 O
intercurrent 17 29 2336 2348 O
illness 30 37 2349 2356 O
including 38 47 2357 2366 O
, 47 48 2366 2367 O
but 49 52 2368 2371 O
not 53 56 2372 2375 O
limited 57 64 2376 2383 O
to 65 67 2384 2386 O
, 67 68 2386 2387 O
uncontrolled 69 81 2388 2400 B-chronic_disease
infection 82 91 2401 2410 I-chronic_disease
, 91 92 2410 2411 O
disseminated 93 105 2412 2424 B-chronic_disease
intravascular 106 119 2425 2438 I-chronic_disease
coagulation 120 131 2439 2450 B-chronic_disease
, 131 132 2450 2451 O
or 133 135 2452 2454 O
psychiatric 136 147 2455 2466 B-chronic_disease
illness 148 155 2467 2474 I-chronic_disease
that 156 160 2475 2479 O
would 161 166 2480 2485 O
limit 167 172 2486 2491 O
compliance 173 183 2492 2502 O
with 184 188 2503 2507 O
study 189 194 2508 2513 O
requirements 195 207 2514 2526 O

has 0 3 2527 2530 O
uncontrolled 4 16 2531 2543 O
, 16 17 2543 2544 O
clinically 18 28 2545 2555 O
significant 29 40 2556 2567 O
pulmonary 41 50 2568 2577 B-chronic_disease
disease 51 58 2578 2585 I-chronic_disease
( 59 60 2586 2587 O
e.g. 60 64 2587 2591 O
, 64 65 2591 2592 O
chronic 66 73 2593 2600 B-chronic_disease
obstructive 74 85 2601 2612 I-chronic_disease
pulmonary 86 95 2613 2622 I-chronic_disease
disease 96 103 2623 2630 I-chronic_disease
, 103 104 2630 2631 O
pulmonary 105 114 2632 2641 B-chronic_disease
hypertension 115 127 2642 2654 I-chronic_disease
) 127 128 2654 2655 O
that 129 133 2656 2660 O
, 133 134 2660 2661 O
in 135 137 2662 2664 O
the 138 141 2665 2668 O
Investigator 142 154 2669 2681 O
's 154 156 2681 2683 O
opinion 157 164 2684 2691 O
, 164 165 2691 2692 O
would 166 171 2693 2698 O
put 172 175 2699 2702 O
the 176 179 2703 2706 O
patient 180 187 2707 2714 O
at 188 190 2715 2717 O
significant 191 202 2718 2729 O
risk 203 207 2730 2734 O
for 208 211 2735 2738 O
pulmonary 212 221 2739 2748 O
complications 222 235 2749 2762 O
during 236 242 2763 2769 O
the 243 246 2770 2773 O
study 247 252 2774 2779 O

history 0 7 2780 2787 O
of 8 10 2788 2790 O
myocardial 11 21 2791 2801 B-chronic_disease
infarction 22 32 2802 2812 I-chronic_disease
or 33 35 2813 2815 O
stroke 36 42 2816 2822 B-chronic_disease
within 43 49 2823 2829 O
6 50 51 2830 2831 B-upper_bound
months 52 58 2832 2838 I-upper_bound
of 59 61 2839 2841 O
study 62 67 2842 2847 O
entry 68 73 2848 2853 O

male 0 4 2854 2858 B-gender

non 0 3 2859 2862 B-cancer
- 3 4 2862 2863 I-cancer
melanoma 4 12 2863 2871 I-cancer
skin 13 17 2872 2876 I-cancer
cancer 18 24 2877 2883 I-cancer

organ 0 5 2884 2889 O
- 5 6 2889 2890 O
confined 6 14 2890 2898 O
prostate 15 23 2899 2907 B-cancer
cancer 24 30 2908 2914 I-cancer
with 31 35 2915 2919 O
no 36 38 2920 2922 O
evidence 39 47 2923 2931 O
of 48 50 2932 2934 O
progressive 51 62 2935 2946 B-chronic_disease
disease 63 70 2947 2954 I-chronic_disease

pregnant 0 8 2955 2963 B-pregnancy

receiving 0 9 2964 2973 O
immunosuppressive 10 27 2974 2991 B-treatment
therapy 28 35 2992 2999 I-treatment

uncontrolled 0 12 3000 3012 B-chronic_disease
angina 13 19 3013 3019 I-chronic_disease

uncontrolled 0 12 3020 3032 O
hypertension 13 25 3033 3045 B-chronic_disease
or 26 28 3046 3048 O
clinically 29 39 3049 3059 O
significant 40 51 3060 3071 O
arrhythmias 52 63 3072 3083 B-chronic_disease
not 64 67 3084 3087 O
controlled 68 78 3088 3098 O
by 79 81 3099 3101 O
medication 82 92 3102 3112 B-treatment
) 92 93 3112 3113 O

≥18 0 3 3114 3117 O
years 4 9 3118 3123 I-lower_bound
old 10 13 3124 3127 O

